Literature DB >> 6446899

Isolation and characterization of sulphated mucopolysaccharides from rat leukaemic (RBL-1) basophils.

D D Metcalfe, S I Wasserman, K F Austen.   

Abstract

Proteoglycans of 300 000 mol.wt. were isolated from dispersed rat basophil tumour cells after labelling of the sulphated mucopolysaccharides with 35S in vitro:90% of the 35S-labelled mucopolysaccharides were extracted at high salt concentration. Alkali degradation of the 35S-labelled proteoglycans yielded glycosaminoglycan chains of 40 000 mol.wt. The composition of the salt-extracted 35S-labelled mucopolysaccharides, as defined by parallel or sequential degradation with chondroitinase AC, chondroitinase ABC and heparinase and resolution of the disaccharide-digestion products obtained with chondroitinase AC, was 48--61% chondroitin 4-sulphate, 20--30% dermatan sulphate, 10--15% heparin and 7--9% chondroitin 6-sulphate. Most of the salt-extracted 35S-labelled mucopolysaccharides were highly charged, with heparin and chondroitin 6-sulphate being relatively uniform in this regard, whereas chondroitin 4-sulphate and dematan sulphate exhibited a range of charge characteristics. The diversity of sulphated mucopolysaccharides present in the rat leukaemic basophil is in contrast with the predominance of heparin in the rat mast cell.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6446899      PMCID: PMC1161362          DOI: 10.1042/bj1850367

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock.

Authors:  W E BROCKLEHURST
Journal:  J Physiol       Date:  1960-06       Impact factor: 5.182

2.  Cell recognition and adhesiveness: a possible biological role for the sulfated mucopolysaccharides.

Authors:  C P Dietrich; L O Sampaio; O M Toledo; C M Cássaro
Journal:  Biochem Biophys Res Commun       Date:  1977-03-21       Impact factor: 3.575

3.  Identification and characterization of arylsulfatase A and B of the rat basophil leukemia tumor.

Authors:  S I Wasserman; K F Austen
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

4.  Immunologic release of heparin from purified rat peritoneal mast cells.

Authors:  R W Yurt; R W Leid; J Spragg; K F Austen
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

5.  Sulfated mucopolysaccharides and basophilic leucocytes in rabbits on a high cholesterol-oil diet.

Authors:  T K Sue; L B Jaques
Journal:  Proc Soc Exp Biol Med       Date:  1974-09

6.  The chondroitin 4-sulfate-protein linkage.

Authors:  U Lindahl; L Rodén
Journal:  J Biol Chem       Date:  1966-05-10       Impact factor: 5.157

7.  Basophilic leukaemia in the albino rat and a demonstration of the basopoietin.

Authors:  E Eccleston; B J Leonard; J S Lowe; H J Welford
Journal:  Nat New Biol       Date:  1973-07-18

8.  Characterization of the target cell receptor for IgE. III. properties of the receptor isolated from rat basophilic leukemia cells by affinity chromatography.

Authors:  D H Conrad; A Froese
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

9.  Biosynthesis of glycosaminoglycans by cultured mastocytoma cells.

Authors:  R G Lewis; A F Spencer; J E Silbert
Journal:  Biochem J       Date:  1973-06       Impact factor: 3.857

10.  The isolation and characterization of glycopeptides and mucopolysaccharides from plasma membranes of an ascites hepatoma, AH 130 FN.

Authors:  S Mutoh; I Funakoshi; I Yamashina
Journal:  J Biochem       Date:  1976-11       Impact factor: 3.387

View more
  5 in total

1.  Generation of leukotriene C4 from a subclass of mast cells differentiated in vitro from mouse bone marrow.

Authors:  E Razin; J M Mencia-Huerta; R A Lewis; E J Corey; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

2.  Glycosaminoglycans in rat mucosal mast cells.

Authors:  L Enerbäck; S O Kolset; M Kusche; A Hjerpe; U Lindahl
Journal:  Biochem J       Date:  1985-04-15       Impact factor: 3.857

3.  Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase.

Authors:  M D Kazatchkine; D T Fearon; D D Metcalfe; R D Rosenberg; K F Austen
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

Review 4.  Serglycin: at the crossroad of inflammation and malignancy.

Authors:  Angeliki Korpetinou; Spyros S Skandalis; Vassiliki T Labropoulou; Gianna Smirlaki; Argyrios Noulas; Nikos K Karamanos; Achilleas D Theocharis
Journal:  Front Oncol       Date:  2014-01-13       Impact factor: 6.244

Review 5.  Mast cell glycosaminoglycans.

Authors:  B Mulloy; R Lever; C P Page
Journal:  Glycoconj J       Date:  2016-11-30       Impact factor: 2.916

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.